Clinical Trials Directory

Trials / Completed

CompletedNCT02741375

Cerebral Oximetry As an Auxiliary Diagnostic Tool in the Diagnosis of Brain Death

Status
Completed
Phase
Study type
Observational
Enrollment
78 (actual)
Sponsor
Karadeniz Technical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Aim: To investigate the efficacy of cerebral oximetry (CO) as an auxiliary diagnostic tool in confirming brain death (BD). Materials and Methods: This observational and interventional study was performed on patients with suspected BD in emergency departments and intensive care units. CO monitoring was performed for at least 6 h, and cerebral tissue oxygen saturation (ScO2) was recorded. Basal ScO2 values (basal ScO2), ScO2 values after 6 h (end ScO2), mean ScO2 values during monitoring (mean ScO2), and minimum (min ScO2) and maximum (max ScO2) ScO2 values observed during monitoring were recorded for all patients. Patients with diagnosis of BD confirmed by the organ transplantation and brain death committee were enrolled as the BD group and other patients as the non-BD group, and cerebral oxygen parameters were compared.

Detailed description

Brain death (BD) means the irreversible loss of all brain and brain stem functions and physiopathologically the cessation of intracranial circulation. BD is a clinical diagnosis that can be made with various clinical tests. However, in order for BD to be definitely established, clinical tests performed initially need to be repeated after 24 h or to be confirmed by corroboratory tests. In addition, the obligation to confirm BD using corroboratory tests varies in current guidelines from country to country but has been eliminated except for certain specific circumstances. However, considering the adverse effects on patients awaiting donor and organ donations of the time lapse between initial and repeat tests in order to confirm BD, more rapid confirmation of definite BD is commonly made using corroboratory tests. This study was planned with the hypothesis that this non-invasive technique using NIRS technology can be an auxiliary tool in the diagnosis of BD. This study was performed with patients with suspected BD in emergency departments and intensive care units and was intended to evaluate the effectiveness of cerebral oximetry as an auxiliary diagnostic tool in patients with suspected BD.

Conditions

Interventions

TypeNameDescription
DEVICESomanetics 5100c (Invos oximeter cerebral/somatic Troy, MI, USA)All patients underwent at least 6-h NIRS monitoring using a Somanetics 5100c (Invos oximeter cerebral/somatic Troy, MI, USA) cerebral oximeter in order to determined cerebral oximetry changes.

Timeline

Start date
2014-01-01
Primary completion
2015-06-01
Completion
2015-07-01
First posted
2016-04-18
Last updated
2016-04-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02741375. Inclusion in this directory is not an endorsement.

Cerebral Oximetry As an Auxiliary Diagnostic Tool in the Diagnosis of Brain Death (NCT02741375) · Clinical Trials Directory